U.S. Markets closed

Hemispherx Biopharma, Inc. (HEB)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.46-0.02 (-4.17%)
At close: 4:00PM EDT

0.46 -0.00 (-0.87%)
After hours: 6:10PM EDT

People also watch
GNBTCVMCTICBCRXVICL
Full screen
Previous Close0.48
Open0.48
Bid0.46 x 10100
Ask0.49 x 500
Day's Range0.46 - 0.48
52 Week Range0.39 - 2.64
Volume237,877
Avg. Volume322,279
Market Cap13.42M
Beta-0.60
PE Ratio (TTM)-1.30
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETFs with exposure to Hemispherx Biopharma, Inc. : July 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hemispherx Biopharma, Inc. Here are 5 ETFs with the largest exposure to HEB-US. Comparing the performance and risk of Hemispherx Biopharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube27 days ago

    ETFs with exposure to Hemispherx Biopharma, Inc. : June 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hemispherx Biopharma, Inc. Here are 5 ETFs with the largest exposure to HEB-US. Comparing the performance and risk of Hemispherx Biopharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Hemispherx Biopharma, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hemispherx Biopharma, Inc. Here are 5 ETFs with the largest exposure to HEB-US. Comparing the performance and risk of Hemispherx Biopharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)